SYRE Spyre Therapeutics, Inc.
$89.93
Spyre Therapeutics, Inc. (SYRE) Earnings News
Earnings press releases, previews and reviews for Spyre Therapeutics, Inc. (SYRE), newest first.
Tuesday
August 4, 2026
4:02 PM ET
Spyre Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Tuesday
May 5, 2026
8:00 AM ET
Spyre Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Monday
April 13, 2026
7:00 AM ET
Spyre Announces Potential Best-in-Class SPY001 Part A Induction Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients
Friday
April 10, 2026
4:05 PM ET
Spyre Therapeutics to Host Conference Call to Report SPY001 Part A Induction Topline Results from SKYLINE Trial in Moderate-to-Severe Ulcerative Colitis Patients on April 13, 2026